Table III. Results of retrospective study on 470 adults observed over 14-year period (1989-2002) and under same continuous treatment with follow-up from 7 to 80 months (subjects with follow-up < 6 months were excluded).

Head and neck diseases in HIV patients		Group 1	Group 2
Tumours	Systemic KS with oral involvement	5/250 (2%)	0/220
	NHL (maxillary sinus)	1/250	0/220
	Pharynx carcinoma	1/250	0/220
	Total tumours	7/250 (3%)	0/220 (0%)
Infections	Oropharyngeal candidiasis	115/250 (46%)	22/220 (10%)
	Acute viral/bacterial pharyngitis	45/250 (18%)	25/220 (11%)
	Acute/chronic sinusitis	14/250 (6%)	6/220 (3%)
	Acute/chronic otitis media	12/250 (5%)	4/220 (2%)
	Total infections	186/250 (75%)	57/220 (26%)
Others	Benign lymphoepithelial parotid cysts	3/250 (1%)	0/220 (0%)
	Sudden hearing loss	0/250 (0%)	2/220 (1%)
Total		196/250 (79%)	59/220 (27%)